Holen Sie sich die Stockscreener-App
5.39
3.06%
0.16
Finanzdaten der Aligos Therapeutics Inc-Aktie (ALGS)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
100.00%
-
|
2.83 | 0.169 | 0.741 | 0.965 |
| Operating Expenses |
0.31%
29.67
|
29.76 | 21.98 | 29.10 | 19.53 |
| Operating Income/Loss |
92.98%
-1.89
|
-26.93 | -21.81 | -28.36 | -18.57 |
| Net Interest Income/Expense |
100.00%
0.20
|
0.10 | 0.60 | 0.40 | 0.40 |
| Income/Loss From Continuing Operations Before Tax |
105.75%
1.307
|
-22.72 | -19.85 | -31.48 | -15.68 |
| Income Tax Expense/Benefit |
786.75%
2.811
|
0.317 | 0.03 | 0.056 | 0.185 |
| Net Income/Loss |
93.47%
-1.504
|
-23.04 | -19.88 | -31.54 | -15.86 |
| Basic Average Shares |
0.27%
10.43
|
10.40 | 0.1681 | 10.37 | 10.35 |
| Diluted Average Shares |
0.27%
10.43
|
10.40 | 0.1681 | 10.37 | 10.35 |
| Basic Earnings Per Share |
93.67%
-0.14
|
-2.21 | -2.01 | -3.04 | -1.53 |
| Diluted Earnings Per Share |
93.67%
-0.14
|
-2.21 | -2.01 | -3.04 | -1.53 |
1.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):